UPDATE 1-Merck stops giving clot drug in study, shares drop
January 13, 2011 at 09:41 AM EST
NEW YORK, Jan 13 (Reuters) - Merck & Co said on Thursday it stopped giving one of its most important experimental drugs, the blood clot preventer Vorapaxar, to patients in one study and to some patients in another late-stage trial.
